Methylated arginines and nitric oxide in end-stage renal disease: impact of inflammation, oxidative stress and haemodialysis

References

• Annuk M, Zilmer M, Lind L, et al. (2001). Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12:2747–52
   PubMed Web of Science ®Google Scholar
• Aucella F, Maas R, Vigilante M, et al. (2009). Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. Atherosclerosis 207:541–5
   PubMed Web of Science ®Google Scholar
• Baylis C. (2006). Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2:209–20
   PubMedGoogle Scholar
• Bode-Boger SM, Scalera F, Kielstein JT, et al. (2006). Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 17:1128–34
   PubMed Web of Science ®Google Scholar
• Boger RH, Endres HG, Schwedhelm E, et al. (2011). Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. J Intern Med 269:349–61
   PubMed Web of Science ®Google Scholar
• Cavusoglu E, Ruwende C, Chopra V, et al. (2010). Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 210:226–31
   PubMed Web of Science ®Google Scholar
• Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, et al. (1996). Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 21:845–53
   PubMed Web of Science ®Google Scholar
• Closs EI, Basha FZ, Habermeier A, Forstermann U. (1997). Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1:65–73
   PubMed Web of Science ®Google Scholar
• Druhan LJ, Forbes SP, Pope AJ, et al. (2008). Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry 47:7256–63
   PubMed Web of Science ®Google Scholar
• Forstermann U. (2010). Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459:923–39
   PubMed Web of Science ®Google Scholar
• Galli F. (2007). Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant 22:v20–36
   PubMed Web of Science ®Google Scholar
• Hewitson CL, Whiting MJ, Barbara JA, et al. (2007). Acute effects of haemodialysis on biochemical modulators of endothelial function. J Intern Med 262:571–80
   PubMed Web of Science ®Google Scholar
• Khaper N, Bryan S, Dhingra S, et al. (2010). Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid Redox Signal 13:1033–49
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Salpeter SR, Bode-Boeger SM, et al. (2006). Symmetric dimethylarginine (SDMA) as endogenous marker of renal function – a meta-analysis. Nephrol Dial Transplant 21:2446–51
   PubMed Web of Science ®Google Scholar
• Landmesser U, Dikalov S, Price SR, et al. (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201–9
   PubMed Web of Science ®Google Scholar
• Leiper J, Murray-Rust J, McDonald N, Vallance P. (2002). S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci USA 99:13527–32
   PubMed Web of Science ®Google Scholar
• Lluch P, Torondel B, Medina P, et al. (2004). Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. J Hepatol 41:55–9
   PubMed Web of Science ®Google Scholar
• Locatelli F, Canaud B, Eckardt KU, et al. (2003). Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272–80
   PubMed Web of Science ®Google Scholar
• MacAllister RJ, Whitley GS, Vallance P. (1994). Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 45:737–42
   PubMed Web of Science ®Google Scholar
• Martens CR, Edwards DG. (2011). Peripheral vascular dysfunction in chronic kidney disease. Cardiol Res Pract 2011:267257
   PubMedGoogle Scholar
• Meinitzer A, Kielstein JT, Pilz S, et al. (2011). Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57:112–21
   PubMed Web of Science ®Google Scholar
• Mimic-Oka J, Simic T, Djukanovic L, et al. (1999). Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 51:233–41
   PubMed Web of Science ®Google Scholar
• Moshage H, Kok B, Huizenga JR, Jansen PL. (1995). Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 41:892–6
   PubMed Web of Science ®Google Scholar
• Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. (2001). Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16:335–40
   PubMed Web of Science ®Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, et al. (1997). Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43:1209–14
   PubMed Web of Science ®Google Scholar
• Nijveldt RJ, Van Leeuwen PA, Van Guldener C, et al. (2002). Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 17:1999–2002
   PubMed Web of Science ®Google Scholar
• Oner-Iyidogan Y, Oner P, Kocak H, et al. (2009). Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis. Clin Exp Med 9:235–41
   PubMed Web of Science ®Google Scholar
• Otsuji S, Shibata H, Umeda M. (1982). Turbidimetric immunoassay of serum C-reactive protein. Clin Chem 28:2121–4
   PubMed Web of Science ®Google Scholar
• Pitocco D, Zaccardi F, Di Stasio E, et al. (2009). Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus. Diabetes Res Clin Pract 86:173–6
   PubMed Web of Science ®Google Scholar
• Pope AJ, Druhan L, Guzman JE, et al. (2007). Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. Am J Physiol Cell Physiol 293:C1679–86
   PubMed Web of Science ®Google Scholar
• Powell LA, Nally SM, McMaster D, et al. (2001). Restoration of glutathione levels in vascular smooth muscle cells exposed to high glucose conditions. Free Radic Biol Med 31:1149–55
   PubMed Web of Science ®Google Scholar
• Pryor WA, Squadrito GL. (1995). The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268:L699–722
   PubMed Web of Science ®Google Scholar
• Raj DS, Vincent B, Simpson K, et al. (2002). Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int 61:697–704
   PubMed Web of Science ®Google Scholar
• Schalkwijk CG, Poland DC, van Dijk W, et al. (1999). Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42:351–7
   PubMed Web of Science ®Google Scholar
• Schepers E, Glorieux G, Dhondt A, et al. (2009). Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant 24:1429–35
   PubMed Web of Science ®Google Scholar
• Schmidt RJ, Domico J, Samsell LS, et al. (1999). Indices of activity of the nitric oxide system in hemodialysis patients. Am J Kidney Dis 34:228–34
   PubMed Web of Science ®Google Scholar
• Schulze F, Carter AM, Schwedhelm E, et al. (2010). Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis 208:518–23
   PubMed Web of Science ®Google Scholar
• Schwedhelm E, Tan-Andresen J, Maas R, et al. (2005). Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma. Clin Chem 51:1268–71
   PubMed Web of Science ®Google Scholar
• Thuraisingham RC, Roberts NB, Wilkes M, et al. (2002). Altered L-arginine metabolism results in increased nitric oxide release from uraemic endothelial cells. Clin Sci (Lond) 103:31–41
   PubMed Web of Science ®Google Scholar
• Tripepi G, Mattace RF, Sijbrands E, et al. (2011). Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol 6:1714–21
   PubMed Web of Science ®Google Scholar
• Usui M, Matsuoka H, Miyazaki H, et al. (1998). Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62:2425–30
   PubMed Web of Science ®Google Scholar
• Vallance P, Leiper J. (2004). Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24:1023–30
   PubMed Web of Science ®Google Scholar
• Vallance P, Leone A, Calver A, et al. (1992). Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572–5
   PubMed Web of Science ®Google Scholar
• White M, Ducharme A, Ibrahim R, et al. (2006). Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond) 110:483–9
   PubMed Web of Science ®Google Scholar
• Woodman RJ. (2008). Does compensatory nitric oxide and angiotensin II receptor activity reduce arterial stiffness in early-stage insulin resistance? Clin Sci (Lond) 114:119–21
   PubMed Web of Science ®Google Scholar
• Zoccali C, Benedetto FA, Maas R, et al. (2002). Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13:490–6
   PubMed Web of Science ®Google Scholar